Institutional investors purchased a net $1.1 million shares of ENTA during the quarter ended September 2015. This may signal that the smart money is gaining interest in this company as the 82.02% of the shares outstanding that institutional investors hold is among the lowest in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
CANDRIAM LUXEMBOURG SA Bought 106.0 Thousand shares of Enanta Pharmaceuticals In...